Mounjaro, a novel medication for treating type 2 diabetes and potentially obesity, has generated significant interest in the UK. Currently, availability is restricted primarily through private prescription services. The expense of Mounjaro can be substantial, typically ranging from around £250 to £450 per period, depending on the prescription and